About
Company
Latest News
Contact Us
History
Careers
Policies
Editorial Policies
Open Access Policy
Research and Publication Ethics
Peer-review Policies
Publication Fees
Advertising Policy
Journals
All Journals
Active Journals
Archived Journals
Services
Language Editing
Layout & Production
Graphic Abstracts
Video Abstracts
Submission System
Collaborations
Strategic Collaborators
Journal Membership
Conference Parterships
Insights
Latest Articles
Academic Talks
Interactive Webinars
Academic Support
Author Hub
Editor Hub
Reviewer Hub
Conference Organizer
Expert Lecture
Search
Log In
Home
Volumes
Volume5
Volume5, Issue1 (2022)
Volume
Auranofin and its analogs as prospective agents for the treatment of colorectal cancer
Efficacy of ICIs on patients with oncogene-driven non-small cell lung cancer: a retrospective study
Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance
Emerging actionable targets to treat therapy-resistant colorectal cancers
HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer
Approaches to identifying drug resistance mechanisms to clinically relevant treatments in childhood rhabdomyosarcoma
Understanding sarcoma drug resistance one cell at a time
Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance
Tumor-derived exosomes: immune properties and clinical application in lung cancer
Immunotherapy resistance of lung cancer
Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer
Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer
ONECUT2 as a key mediator of androgen receptor-independent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer
Drug resistance and minimal residual disease in multiple myeloma
Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma
Emerging mechanisms of immunotherapy resistance in sarcomas
Potential mechanisms of resistance to current anti-thrombotic strategies in Multiple Myeloma
Combating CHK1 resistance in triple negative breast cancer: EGFR inhibition as potential combinational therapy
Lysosome-mediated chemoresistance in acute myeloid leukemia
<i>In vitro </i>cultures of circulating tumor cells: a potential tool to unravel drug sensitivity
Actions for 0 selected articles
Download PDFs >
Cancer Drug Resistance
ISSN 2578-532X (Online)
editorial@cdrjournal.com
Navigation
Contact Us
Sitemap
Follow Us
LinkedIn
Twitter
WeChat
Navigation
Contact Us
Sitemap
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/